KD025: Expiry of patents related to composition-of-matter and method of use for fibrosis in US in 2029 and Canada, China, Eurasia, Europe, and Japan in 2026. (Kadmon) - Mar 6, 2020 - Annual Report 2019: Expiry of patents related to method of use for cGVHD in US in 2035 and for immune diseases including GVHD in US, Japan, Canada, China, Eurasia, and Europe in 2033
Patent
|